Drawing for AXIOM CLINICAL RESEARCH

USPTO serial 87181334

AXIOM CLINICAL RESEARCH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CIANCI, RYAN MICHAEL
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AXIOM CLINICAL RESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Margaret A. Lawson

MARGARET A. LAWSON TAFT STETTINIUS & HOLLISTER LLP425 WALNUT STREETSUITE 1800CINCINNATI, OH 45202

Goods and services

ClassDescriptionStatusFirst use
041Conduct training and provide education to Principle Investigators, Clinical Subjects, Sponsors and other persons interested in learning about clinical researchACTIVEOct 17, 2016
042Clinical research organization, namely, conducting early phase clinical research, observational studies and Phase I and II clinical trials; collecting, reposing, analyzing data to support scientific advancements and unmet clinical needs and prepare documentation for presentations to Internal Review Boards, Subjects for consenting into trials and the Food and Drug AdministrationACTIVEOct 17, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 9, 2017MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 9, 2017ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 4, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 2016DOCKASSIGNED TO EXAMINER—
Nov 17, 2016AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Nov 17, 2016IUAFUSE AMENDMENT FILED—
Nov 16, 2016EAAUTEAS AMENDMENT OF USE RECEIVED—
Sep 28, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance